RheumaGen
- Biotech or pharma, therapeutic R&D
RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure major autoimmune diseases. RheumaGen focuses on editing the human leukocyte antigen (HLA), or “immune gene,” to develop one-time curative cell and gene therapies.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}